2.100USD-2.55%Mkt Cap: 232.60M USDP/E: —Last update: 2026-06-01
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant m…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap232.60M USD
Enterprise Value67.85M USD
Revenue (TTM)18.42M USD
Gross Profit-88.86M USD
Net Income (TTM)-142.93M USD
Revenue/Share0.1740 USD
Last Price2.100 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees103
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS0144421072
Valuation
P/E (Trailing)—
P/E (Forward)-3.09
PEG—
EV/EBITDA-0.53
EV/Revenue3.68
P/S13.02
P/B22.98
EPS (TTM)-1.19
EPS (Forward)-0.70
52W Range
1.09044% of range3.400
52W High3.400 USD
52W Low1.090 USD
Profitability
Gross Margin0.00%
Oper. Margin-2382.31%
EBITDA Margin0.00%
Profit Margin-679.16%
ROE-466.34%
ROA-48.74%
Growth
Revenue Growth-71.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-184.03M USD
CapEx (TTM)41.00K USD
FCF Margin-646.72%
FCF Yield-51.21%
Net Debt-171.97M USD
Net Debt/EBITDA1.35
Balance Sheet
Debt/Equity1.18
Current Ratio5.25
Quick Ratio5.04
Book Value/Sh0.0940 USD
Cash/Share1.860 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)3.100 USD
Target Range1.000 USD – 6.000 USD
# Analysts5
Ownership
Shares Out.111.03M
Float94.09M
Insiders9.56%
Institutions82.26%
Short Interest
Short Ratio9.3d
Short % Float4.63%
Short % Out.4.38%
Shares Short4.86M
Short (prev mo.)5.15M
Technical
SMA 502.296 (-8.5%)
SMA 2002.118 (-0.9%)
Beta0.65
S&P 52W Chg27.94%
Avg Vol (30d)569.50K
Avg Vol (10d)789.24K
Technical Indicators
RSI (14)45.5
MACD-0.0507
MACD Signal-0.0475
MACD Hist.-0.0032
BB Upper2.565 USD
BB Middle2.240 USD
BB Lower1.915 USD
BB Width29.00%
ATR (14)0.1684 USD
Vol Ratio (20d)1.12x